Trials / Terminated
TerminatedNCT00446589
The Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral Density
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Papageorgiou General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hemodialysis patients with low bone density (total hip T-score \<-2.5) will be assigned to receive teriparatide (those with histologic confirmation of adynamic bone disease) or ibandronate (subjects with increased osteoclast number on bone biopsy). Follow-up period: one year. A second bone biopsy at the end of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ibandronate | iv 1mg ibandronate monthly for one year |
| DRUG | teriparatide | sc injection using a pen like device during every hemodialysis session (thrice a week) |
Timeline
- Start date
- 2006-07-01
- First posted
- 2007-03-13
- Last updated
- 2014-10-29
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT00446589. Inclusion in this directory is not an endorsement.